Annotation Detail

Information
Associated Genes
AGR2
Associated Variants
AGR2 EXPRESSION
AGR2 EXPRESSION
Associated Disease
breast cancer
Source Database
CIViC Evidence
Description
mRNA expression of AGR2 in 61 patients with tamoxifen treated postmenopausal breast cancer was determined by qRT-PCR and was inversely associated with treatment response and progression free survival (p= 0.0011, p = 0.0366 respectively). AGR2 protein expression as assessed by IHC was not significantly associated with treatment outcome.
Variant Origin
N/A
Variant Origin
N/A
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/891
Gene URL
https://civic.genome.wustl.edu/links/genes/8407
Variant URL
https://civic.genome.wustl.edu/links/variants/373
Rating
1
Evidence Type
Predictive
Disease
Breast Cancer
Evidence Direction
Supports
Drug
Tamoxifen
Evidence Level
B
Clinical Significance
Resistance
Pubmed
24167368
Drugs
Drug NameSensitivitySupported
TamoxifenResitance or Non-Reponsetrue